ISSN 2409-5834

Effects pf Biological Response Modifiers on the Prevalence pf Autoantibodies to Vascular Injury in Agroup of Iraqi Patients with Autoimmune Disease

Main Article Content

Jamal Nasser Farhood


Background; .biological disease modifiers mainly those targeting tumor necrosis factor (Etanercept), (Infliximab), together with (Adalimumab) are currently an important part of the treatment plan for seropositive poly-articular arthropathy. Since these drugs greatly affect the course of the disease, they alter the treatment of this condition and significantly slow down X-ray progression of the aforementioned condition.

Article Details